Tidal Trust II YieldMax SNOW Option Income Strategy ETF (ARCA: SNOY)

Ultime notizie per Tidal Trust II YieldMax SNOW Option Income Strategy ETF (ARCA:SNOY)

The Fund is an actively managed exchange-traded fund (ETF) that seeks current income while providing indirect exposure to the share price (i.e., the price returns) of the common stock of Snowflake Inc. (SNOW), subject to a limit on potential investment gains.

First American Government Obligations Fund

YieldMax SNOW Option Income Strategy ETF

Tidal Trust II YieldMax SNOW Option Income Strategy ETF

Wells Fargo analyst Michael Turrin maintains Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) with a Overweight and raises the price target from $515 to $565.

News

Price Target

Analyst Ratings

MSFT

Wells Fargo Maintains Overweight on Microsoft, Raises Price Target to $565

Wells Fargo analyst Michael Turrin maintains Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) with a Overweight and raises the price target from $825 to $880.

INTU

Wells Fargo Maintains Overweight on Intuit, Raises Price Target to $880

UBS analyst Joseph Spak maintains Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) with a Buy and raises the price target from $20 to $22.

UBS Maintains Buy on Dana, Raises Price Target to $22

Lennar Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) will release earnings results for the second quarter, after the <a href="https://www.benzinga.com/quote/LEN/earnings">closing bell on Monday, June 16.</a>
Analysts expect the Miami, Florida-based company to report quarterly earnings at $1.94 per share, down from $3.38 per share in the year-ago period. Lennar projects to report quarterly revenue at $8.19 billion, compared to $8.77 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 9, the company's board declared a quarterly cash dividend of 50 cents per share for both Class A and Class B common stock.
Lennar shares gained 0.6% to close at $112.15 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/LEN/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Wells Fargo analyst Deepa Raghavan maintained an Equal-Weight rating and cut the price target from $120 to $110 on April 9, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintained a Market Perform rating and cut the price target from $141 to $128 on March 25, 2025. This analyst has an accuracy rate of 67%.</li>
<li>UBS analyst John Lovallo maintained a Buy rating and cut the price target from $183 to $164 on March 24, 2025. This analyst has an accuracy rate of 65%.</li>
<li>RBC Capital analyst Mike Dahl maintained a Sector Perform rating and slashed the price target from $125 to $122 on March 24, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Barclays analyst Matthew Bouley maintained an Equal-Weight rating and cut the price target from $121 to $110 on March 24, 2025. This analyst has an accuracy rate of 72%.</li>
</ul>
Considering buying LEN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/LEN/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="561" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12222313/image-204-1024x561.png" alt="" class="wp-image-948365" style="width:613px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12222313/image-204-1024x561.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12222313/image-204-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12222313/image-204-768x421.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12222313/image-204.png 1145w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45902941/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-q2">Top 2 Defensive Stocks That May Keep You Up At Night In Q2</a> </li>
</ul>
Photo via Shutterstock

Earnings

Markets

Trading Ideas

Lennar Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) slipped amid heightened <a href="https://www.benzinga.com/markets/market-summary/25/06/45918802/middle-east-tensions-rattle-markets-us-stock-futures-slide-oil-jumps-8-gold-surges-above-3400-after-israel-strikes-iran">geopolitical tensions</a> following Israel&#8217;s attack on Iran. Traders questioned whether this signals a full-on crash or a temporary reaction.
What Happened: In an X post on June 13, crypto trader Jackis jokingly called Bitcoin's drop a trip to "Goblin Town"—or if markets are overreacting to fear-inducing headlines. Jackis noted that while the situation is alarming, similar Middle East conflicts have triggered emotional but short-lived market dips in the past. He said this may be another instance of fear-driven selling rather than a genuine breakdown of fundamentals.
Jackis <a href="https://x.com/i_am_jackis/status/1933433496489353649">emphasized</a> that Bitcoin remains in a macro bullish structure, consolidating inside a vertical ascending channel for over 200 days. This consolidation is seen as a re-accumulation phase that typically precedes major breakouts.
<ul class="wp-block-list">
<li>The pullback from May 22 to June 5 ended with a bullish daily structure break and if BTC holds the $100,400 low, the move is likely just a retest.</li>
<li>A massive $1.14 billion liquidation event, the largest since February, may have flushed out weak hands, potentially marking a local bottom, as it did earlier this year.</li>
<li>New liquidity zones have now formed around $111,000.</li>
</ul>
He said the drop is more about fear than fundamentals, highlighting Bitcoin's rising demand and solid on-chain metrics.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45902384/ethereum-etfs-outpace-bitcoin-etfs-with-240m-inflows-on-june-11">Ethereum ETFs Outpace Bitcoin ETFs With $240M Inflows On June 11</a>
What's Next: Jackis advised traders to watch the weekly close for confirmation. If BTC maintains its recent low, an upside continuation is expected. However, if it breaks lower, the next strong support lies at $93,000—though the macrostructure remains intact even in that scenario.
Crypto trader Xremlin <a href="https://x.com/0x_gremlin/status/1933468506365816863">offered</a> a different take, arguing that war has historically been bullish for Bitcoin:
<ul class="wp-block-list">
<li>In April 2024, following Iran&#8217;s attack on Israel, BTC rose 18% in two weeks and 28% over 1.5 months.</li>
</ul>
<ul class="wp-block-list">
<li>In October 2024, Bitcoin surged 10% in the first week after renewed conflict and 62% over the following two months after Israel struck back.</li>
</ul>
Now, in June 2025, Bitcoin has dropped 2.5% in response to similar news. Xremlin remains curious: Will the historical pattern repeat?
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45837005/strategy-buys-another-110-million-in-bitcoin-now-holds-582000-btc">Strategy Buys Another $110 Million In Bitcoin, Now Holds 582,000 BTC</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Will Bitcoin Crash To 'Goblin Town' Or Is This Just A Geopolitical Overreaction?

UBS analyst Leonardo Olmos maintains Vtex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTEX#NYSE">VTEX</a>) with a Buy and lowers the price target from $11 to $10.

VTEX

UBS Maintains Buy on Vtex, Lowers Price Target to $10

Like many financial gurus, Ramit Sethi believes you should track your spending, use your money wisely, and invest for long-term wealth. However, he doesn't believe you should penny-pinch along the way. He believes in living a rich life as you build wealth, and he <a href="https://www.tiktok.com/@ramit.sethi/video/7513566097874930974?lang=en">criticized a common trend</a> in the personal finance industry where people talk about how much a daily coffee habit costs.
"I know coffee is more expensive," Sethi stated in a recent TikTok video, explaining that he doesn&#8217;t want to hear people talking about how spending $3 per day on coffee is costing your financial future.&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – Many are rushing to <a href="https://www.benzinga.com/money/mode-mobile-2">grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Instead, he framed the conversation around $50,000 questions. Asking questions about your biggest expenses can lead to the most savings. These are some of the expenses Sethi encourages people to look at instead of their daily coffee consumption.
<h2 class="wp-block-heading">Focus On Your Housing Costs</h2>
Sethi likes to look at the numbers, and if you look at anyone's financial profile, you'll see that most of their money goes toward housing. Whether it's monthly mortgage payments or rent, most of your money is probably going toward housing.
People who drink coffee each day can stop drinking coffee on weekends to reduce their coffee spending by 28%. However, that won't be life-changing for your finances. Getting your housing costs down by 10% will be more significant than abandoning your coffee habit altogether.
You can reduce your housing costs by living with a roommate, downsizing, or moving to a more affordable area. You may have to make short-term sacrifices to reduce your housing costs, but if you're really looking to save money, you should start with the biggest line items.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
<h2 class="wp-block-heading">Assess Your Car Payments</h2>
Car payments are typically right behind housing as people's largest expense. Although a good 10% to 15% of your monthly paycheck is a good range for car expenses, many people spend close to 20% of their monthly paycheck on auto loans, gasolin, insurance, and related costs.
You can reduce your car payments by avoiding car leases, as you'll never own a car outright if you keep making lease payments. An auto loan gives you the path to full ownership, but you don't have to borrow money to buy a new car. Opting for a used car can help you save a lot of money while getting a quality vehicle.
Finally, you may have too many cars. Not everyone needs a luxury car, and just because you can afford it doesn't mean you should buy it. Sethi would be a fan of someone buying a luxury car that makes them happy as long as they have their finances in order. If you're living paycheck to paycheck, you should probably get rid of a luxury car and choose a more affordable vehicle instead.
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">Small Expenses Add Up</h2>
Sethi regularly encourages people to track their spending. If the daily coffee habit isn't worth it, then you should remove it from your expenses. Unused subscriptions, impulsive spending, and other purchases that don't make sense also fit in this category.&nbsp;
Every dollar matters, but if you want to save money, focus on the biggest line items in your budget. Housing and car costs are the top two items for most people. These two spending categories make up more than half of most people's budgets.&nbsp;
Regularly monitor your expenses and get rid of the small things that don't make sense. However, Sethi is against sacrificing your happiness and living excessively below your means just to save a few extra dollars. Just make sure you are asking yourself more $50,000 questions and fewer $5 questions.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Ramit Sethi Shoots Down $5 Questions In Favor Of $50,000 Questions: 'I Know Coffee Is More Expensive'

Perma-Pipe Inlt Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPIH#NASDAQ">PPIH</a>) reported quarterly earnings of $0.61 per share. This is a 238.89 percent increase over earnings of $0.18 per share from the same period last year. The company reported $46.75 million in sales this quarter. This is a 36.21 percent increase over sales of $34.32 million the same period last year.

PPIH

Perma-Pipe Inlt Hldgs Q1 EPS $0.61 Up From $0.18 YoY, Sales $46.75M Up From $34.32M YoY

Argus Research analyst John Staszak downgrades McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) from Buy to Hold.

Downgrades

Argus Research Downgrades McDonald's to Hold

UBS analyst Peyton Dorne maintains Magnolia Oil &amp; Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGY#NYSE">MGY</a>) with a Buy and raises the price target from $26 to $29.

UBS Maintains Buy on Magnolia Oil & Gas, Raises Price Target to $29

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>JP Morgan raised Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) price target from $141 to $154. JP Morgan analyst Matthew Boss maintained an Overweight rating. Ross Stores shares closed at $133.47 on Thursday. <a href="https://www.benzinga.com/quote/ROST/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays increased the price target for Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) from $205 to $220. Barclays analyst Gaurav Jain maintained an Overweight rating. Philip Morris shares closed at $184.10 on Thursday. <a href="https://www.benzinga.com/quote/PM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies raised EOG Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EOG#NYSE">EOG</a>) price target from $144 to $148. Jefferies analyst Lloyd Byrne maintained a Buy rating. EOG Resources shares closed at $120.59 on Thursday. See how other analysts <a href="https://www.benzinga.com/quote/EOG/analyst-ratings">view this stock</a>.</li>
<li>Rosenblatt raised the price target for Extreme Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXTR#NASDAQ">EXTR</a>) from $18 to $20. Rosenblatt analyst Mike Genovese maintained a Buy rating. Extreme Networks shares closed at $16.70 on Thursday. <a href="https://www.benzinga.com/quote/EXTR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo raised the price target for DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) from $67 to $80. Wells Fargo analyst Michael Turrin upgraded the stock from Underweight to Equal-Weight. DocuSign shares closed at $76.01 on Thursday. <a href="https://www.benzinga.com/quote/DOCU/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup cut The Sherwin-Williams Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) price target from $405 to $385. Citigroup analyst Patrick Cunningham downgraded the stock from Buy to Neutral. Sherwin-Williams shares settled at $356.20 on Thursday. <a href="https://www.benzinga.com/quote/SHW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies raised Darden Restaurants, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) price target from $165 to $210. Jefferies analyst Andy Barish upgraded the stock from Underperform to Hold. Darden shares closed at $217.81 on Thursday. <a href="https://www.benzinga.com/quote/DRI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Oppenheimer increased Shift4 Payments, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) price target from $121 to $142. Oppenheimer analyst Rayna Kumar maintained an Outperform rating. Shift4 Payments shares closed at $93.31 on Thursday.  <a href="https://www.benzinga.com/quote/FOUR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays boosted the price target for Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) from $202 to $221. Barclays analyst Raimo Lenschow maintained an Overweight rating. Oracle shares settled at $199.86 on Thursday. <a href="https://www.benzinga.com/quote/ORCL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan raised Riot Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) price target from $13 to $14. JP Morgan analyst Reginald Smith maintained an Overweight rating. Riot Platforms shares closed at $10.21 on Thursday. <a href="https://www.benzinga.com/quote/RIOT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ORCL stock? Here&#8217;s what analysts think:

DOCU

EXTR

FOUR

ORCL

RIOT

ROST

Oracle To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Friday

UBS analyst Kevin Mcveigh maintains Automatic Data Processing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) with a Neutral and lowers the price target from $323 to $315.

UBS Maintains Neutral on Automatic Data Processing, Lowers Price Target to $315

Although the broader push for digitalization in theory should promote stability in international relations, cross-border rivalries and tensions have frequently spilled over into violence. The breaking news regarding Israel's<a href="https://www.nbcnews.com/world/iran/live-blog/israel-strikes-iran-middle-east-conflict-live-updates-rcna212727"> strikes</a> on Iran represents just the latest incident of armed conflict. With little to indicate that peaceful solutions are on the table for war-torn regions, the Dow Jones U.S. Select Aerospace &amp; Defense has been one of the top performers this year.
According to an NBC News report, on early Friday local time, Israel launched strikes on Iran, targeting the nation's nuclear program. Adding to concerns of escalation in the Middle East, Israeli Prime Minister Benjamin Netanyahu stated that the operation "will continue for as many days as it takes to remove this threat." In response, stock futures tumbled, though not all sectors suffered the same fate.
In particular, the<a href="https://www.benzinga.com/markets/commodities/25/06/45897276/oil-etfs-surge-over-6-as-trump-orders-middle-east-evacuation-amid-iran-tensions-warns-region-could-be-dangerous"> oil market has been booming</a> in response to rising Middle East tensions. As well, the defense sector – due to a combination of pragmatic and cynical factors – has witnessed a spike in sentiment. On a year-to-date basis, the aforementioned aerospace and defense index gained over 23% of value. In contrast, the benchmark S&amp;P 500 has gained less than 3% during the same period.
To be sure, it's not just the breaking news regarding Israel and Iran that's driving investor flows into the defense ecosystem. Per the Geneva Academy, there are more than 110 armed<a href="https://geneva-academy.ch/galleries/today-s-armed-conflicts"> conflicts</a> around the world, breaking down as follows:
<ul class="wp-block-list">
<li>Middle East and North Africa: More than 45 armed conflicts.</li>
<li>Africa: Over 35 armed conflicts.</li>
<li>Asia: 21 armed conflicts.</li>
<li>Europe: 7 armed conflicts.</li>
<li>Latin America: 6 armed conflicts.</li>
</ul>
Because these conflicts – such as Russia's ongoing invasion of Ukraine – provide no glimpse of an imminent endgame, the matter has prompted aggressive defense spending by international governments. In fact, a recent report by the Stockholm International Peace Research Institute (SIPRI) revealed that<a href="https://www.benzinga.com/25/04/45032800/global-defense-budgets-surge-to-27-trillion-as-europe-and-middle-east-lead-steepest-increase-since-cold-war-report"> global defense budgets reached unprecedented levels</a> last year.
The Direxion ETF: Although it's a contentious topic, it's an unavoidable one. Given the threat that adversarial nations can impose unilateral (and kinetic) actions against their neighbors, defense spending has become a priority. Subsequently, this dynamic boosts demand for the myriad enterprises in the war machine industry.
For traders simply following capital inflows, the <a href="https://www.direxion.com/product/daily-aerospace-defense-bull-3x-etf?utm_source=Referral&amp;utm_medium=Native&amp;utm_source_platform=Benzinga&amp;utm_campaign=LandI_Product_DFEN">Direxion Daily Aerospace &amp; Defense Bull 3X Shares</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFEN#NYSE">DFEN</a>) could represent an interesting platform. An ultra-leveraged exchange-traded fund, DFEN seeks the daily investment results of 30% of the performance of the Dow Jones U.S. Select Aerospace &amp; Defense index.
Primarily, the attraction toward the DFEN ETF is that it offers a convenient mechanism for speculation. Ordinarily, those interested in leverage must participate in the options market. However, many options strategies may feature high complexities. On the flip side, Direxion ETFs are intuitive as the underlying units can be bought and sold much like any other publicly traded security. Therefore, the learning curve is shallow.
Still, traders must be aware of the risks of ultra-leveraged ETFs. First, 3X funds like DFEN are extremely volatile. While the good times are great, the bad times are horrific – volatility cuts both ways. Second, these specialized vehicles are designed for exposure lasting no longer than one day. Holding beyond this recommended period may expose investors to value decay due to the daily compounding effect.
The DFEN ETF: Thanks to the chaotic geopolitical environment, the DFEN ETF has been a strong performer, gaining nearly 64% since the start of the year.
<ul class="wp-block-list">
<li>The past month offered rich headlines, driving the 3X defense fund to a return of nearly 23%.</li>
<li>So far, momentum has been strong for the DFEN ETF, which trades above its 20-day exponential moving average (EMA), along with the 50- and 200-day moving averages (DMAs).</li>
<li>Ordinarily, a breather may be called for due to the strong run. However, recent tensions may see a detour from this expected outcome.</li>
</ul>
<figure class="wp-block-image"><img loading="lazy" decoding="async" width="997" height="632" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13091151/image-223.png" alt="" class="wp-image-949065" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13091151/image-223.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13091151/image-223-300x190.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13091151/image-223-768x487.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></figure>
Featured<a href="https://pixabay.com/photos/sunrise-airplane-fighter-silhouette-86008/"> image</a> by Canva.

Long Ideas

Short Ideas

Technicals

ETFs

DFEN

Soaring Middle East Tensions Place The Spotlight Firmly On Direxion's DFEN ETF

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">89.36</td>
<td align="right">2.77</td>
<td align="right">3.19</td>
<td>976.3K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">210.80</td>
<td align="right">-2.91</td>
<td align="right">-1.37</td>
<td>7.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">239.67</td>
<td align="right">-2.90</td>
<td align="right">-1.20</td>
<td>41.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">50.40</td>
<td align="right">-0.60</td>
<td align="right">-1.18</td>
<td>429.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">102.65</td>
<td align="right">-0.98</td>
<td align="right">-0.95</td>
<td>5.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">142.80</td>
<td align="right">-1.06</td>
<td align="right">-0.74</td>
<td>11.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">136.01</td>
<td align="right">-0.80</td>
<td align="right">-0.59</td>
<td>4.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">81.60</td>
<td align="right">-0.29</td>
<td align="right">-0.36</td>
<td>3.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">42.10</td>
<td align="right">-0.13</td>
<td align="right">-0.31</td>
<td>738</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.77</td>
<td align="right">-0.19</td>
<td align="right">-0.24</td>
<td>36.5K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For June 13, 2025

Millicom International Cellular S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGO#NASDAQ">TIGO</a>) today announced the partial closing of its previously disclosed transaction with SBA Communications Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>), through the sale of LATI International S.A., the Luxembourg-based holding company for Millicom's mobile passive infrastructure assets in Central America. To date, completed closings have generated approximately $600 million in proceeds, with the remainder of the approximately $975 million transaction expected to close in Q3 2025.
In conjunction with this strategic milestone, Millicom's Board of Directors intends, following the publication of Millicom's Q2 results, to approve the distribution of a special interim cash dividend of $2.50 per share, representing approximately 45% of the net proceeds of the transaction. The dividend will be distributed in two equal installments of $1.25 per share, on or around October 15, 2025 and April 15, 2026.
This special dividend is incremental to Millicom's previously announced annual dividend of $3.00 per share, further reflecting the Company's ongoing commitment to shareholder remuneration.
This transaction highlights Millicom's strategic commitment to monetizing infrastructure assets, strengthening financial flexibility, and generating sustainable shareholder returns—while reaffirming its disciplined approach to capital structure by maintaining its leverage target range of 2.0-2.5x.

SBAC

TIGO

Millicom Announces Partial Closing Of Infrastructure Deal With SBA Communications; Intends To Declare Special Dividend Of $2.50/Shr Representing Around 45% Of The Proceeds

Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) with a Neutral and raises the price target from $157 to $170.

Citigroup Maintains Neutral on Cardinal Health, Raises Price Target to $170

On Friday, AstraZeneca Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group Limited.
Per the agreement, AstraZeneca and CSPC <a target="_blank" href="https://www.astrazeneca.com/media-centre/press-releases/2025/astrazeneca-enters-into-collaboration-with-cspc.html" rel="noreferrer noopener">agree</a> to discover and develop preclinical candidates for multiple targets with the potential to treat diseases across chronic indications, including a preclinical small molecule oral therapy <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">for immunological diseases</a>.
Financial Considerations
CSPC will receive an upfront payment of $110 million and is also eligible to receive up to $1.62 billion in potential development milestone payments and up to $3.6 billion in sales milestone payments, plus potential single-digit royalties based on annual net sales of the products.
Under the agreement, AstraZeneca will have the right to exercise options for exclusive licenses to develop and commercialize worldwide candidates identified under this agreement.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/health-care/25/06/45729253/astrazeneca-highlights-significant-gains-across-three-major-cancer-trials-at-asco" rel="noreferrer noopener">AstraZeneca Highlights Significant Gains Across Three Major Cancer Trials At ASCO</a>
CSPC will conduct research in Shijiazhuang City, utilizing its AI-driven, dual-engine efficient drug discovery platform.
This platform uses AI technology to analyze the binding patterns of target proteins with existing compound molecules and conduct targeted optimization to select highly effective small molecules with excellent developability.
The collaboration furthers AstraZeneca&#8217;s presence in China following the&nbsp;$2.5 billion investment in Beijing&nbsp;announced earlier this year and strengthens the ongoing collaboration with CSPC.
In March, the European pharma giant said the investment over the next five years is part of a strategic partnership with the Beijing Municipal Government and the Beijing Economic-Technological Development Area Administrative Office, which includes agreements with three biotechs and follows the <a target="_blank" href="https://www.benzinga.com/25/02/43859578/amid-mounting-pressure-in-china-astrazeneca-buys-fibrogens-chinese-unit-for-160-million-and-gains-access-to-anemia-drug" rel="noreferrer noopener">recent Fibrogen announcement</a>.
AstraZeneca expects its Beijing workforce to grow to 1,700 employees.
In October 2024, AstraZeneca entered into an exclusive license agreement with CSPC Pharmaceutical to advance the development of an early-stage, novel small molecule Lipoprotein (a) (Lp(a)) disruptor for dyslipidemia, a condition characterized by abnormal levels of lipids (fats) in the blood.&nbsp;
It&#8217;s a significant risk factor for cardiovascular disease, including heart attack and stroke.
Under the agreement, AstraZeneca <a target="_blank" href="https://www.astrazeneca.com/media-centre/press-releases/2024/astrazeneca-licenses-lipid-lowering-lpa-asset.html" rel="noreferrer noopener">received</a> access to CSPC&#8217;s preclinical candidate small molecule, YS2302018, as a lipid-lowering therapy with potential in a range of cardiovascular disease indications alone or in combination, including with the oral small molecule PCSK9 inhibitor AZD0780.
CSPC received an upfront payment of $100 million from AstraZeneca and is also eligible to receive up to $1.92 billion for further development and commercialization milestones, plus tiered royalties.
Price Action: At the last check on Friday, AZN stock was down 0.53% to $74.60 during the premarket session.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/m-a/25/06/45907865/biontech-mrna-cancer-portfolio-curevac-all-stock-deal" target="_blank" rel="noreferrer noopener">BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal</a></li>
</ul>
Photo: Shutterstock

Biotech

Large Cap

Health Care

Contracts

General

AstraZeneca Inks Research Pact With China's CSPC Pharmaceuticals Focused On AI-Driven Research, Valued Up To $5.33 Billion

– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma –
– Rademikibart reduced annualized exacerbations in patients with eosinophilic-driven type 2 asthma –
– Data supports ongoing Phase 2 acute exacerbation studies in asthma and COPD; expect to report topline data from both studies in 1H26 –
SAN DIEGO, June 13, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTB#NASDAQ">CNTB</a>) ("Connect Biopharma" or the "Company"), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic obstructive pulmonary disease (COPD), today announced the presentation of clinical data supporting rademikibart, the Company's investigational, next-generation, potentially best-in-class anti-interleukin-4-receptor alpha (IL-4Rα) antibody, at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress, taking place June 13-16, 2025, in Glasgow, United Kingdom and virtually.

CNTB

Connect Biopharma Presents Clinical Data Supporting Rademikibart, Anti-Interleukin-4-Receptor Alpha Antibody At EAACI 2025 Annual Congress

Citigroup analyst Paul Diamond maintains Comstock Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRK#NYSE">CRK</a>) with a Neutral and raises the price target from $22 to $27.

Citigroup Maintains Neutral on Comstock Resources, Raises Price Target to $27

Citigroup analyst Tyler Radke maintains Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) with a Neutral and raises the price target from $186 to $196.

Comments

Tidal Trust II YieldMax SNOW Option Income Strategy ETF

Notizie

Ultime notizie per Tidal Trust II YieldMax SNOW Option Income Strategy ETF (ARCA:SNOY)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO